Toshiyasu Sasaoka
Department of Clinical Pharmacology
Toyama Medical and Pharmaceutical University
2630 Sugitani
Toyama 930-0194
Japan
Name/email consistency: high
- Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes. Sasaoka, T., Fukui, K., Wada, T., Murakami, S., Kawahara, J., Ishihara, H., Funaki, M., Asano, T., Kobayashi, M. Diabetologia (2005)
- SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. Sasaoka, T., Wada, T., Fukui, K., Murakami, S., Ishihara, H., Suzuki, R., Tobe, K., Kadowaki, T., Kobayashi, M. J. Biol. Chem. (2004)
- Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Sasaoka, T., Kikuchi, K., Wada, T., Sato, A., Hori, H., Murakami, S., Fukui, K., Ishihara, H., Aota, R., Kimura, I., Kobayashi, M. Endocrinology (2003)
- SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Sasaoka, T., Hori, H., Wada, T., Ishiki, M., Haruta, T., Ishihara, H., Kobayashi, M. Diabetologia (2001)
- Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka, T., Ishiki, M., Wada, T., Hori, H., Hirai, H., Haruta, T., Ishihara, H., Kobayashi, M. Endocrinology (2001)
- Synergistic role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase cascade in the regulation of insulin receptor trafficking. Sasaoka, T., Wada, T., Ishihara, H., Takata, Y., Haruta, T., Usui, I., Ishiki, M., Kobayashi, M. Endocrinology (1999)
